4//SEC Filing
Linscott Walt Addison 4
Accession 0001641172-25-003822
CIK 0001857044other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:15 PM ET
Size
16.4 KB
Accession
0001641172-25-003822
Insider Transaction Report
Form 4
Linscott Walt Addison
Chief Operating Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−1,125$66→ 0 totalExercise: $610.24From: 2019-01-22Exp: 2026-01-22→ Common Stock (1,125 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−750$44→ 0 totalExercise: $684.80From: 2017-10-23Exp: 2027-10-23→ Common Stock (750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−1,125$66→ 0 totalExercise: $34.32From: 2020-02-17Exp: 2027-02-17→ Common Stock (1,125 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−2,500$148→ 0 totalExercise: $72.00From: 2019-09-13Exp: 2026-09-13→ Common Stock (2,500 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−1,250$74→ 0 totalExercise: $25.72From: 2020-09-16Exp: 2027-09-16→ Common Stock (1,250 underlying) - Disposition to Issuer
Stock Option (right to buy)
2025-04-10$0.06/sh−1,750$103→ 0 totalExercise: $684.80From: 2017-12-11Exp: 2027-12-11→ Common Stock (1,750 underlying)
Footnotes (1)
- [F1]The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation.
Documents
Issuer
Indaptus Therapeutics, Inc.
CIK 0001857044
Entity typeother
Related Parties
1- filerCIK 0001648585
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:15 PM ET
- Size
- 16.4 KB